TickerFactsScreenerDevelopers

MiNK Therapeutics, Inc. (INKT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$8.34M2021: -$12.83M2022: -$18.87M2023: -$15.76M2024: -$9.56M2025: -$5.93M-$5.93M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$5.93M+38.0%
2024-$9.56M+39.4%
2023-$15.76M+16.5%
2022-$18.87M-47.1%
2021-$12.83M-53.8%
2020-$8.34M—